Cargando…
Serum ATX as a novel biomarker for breast cancer
Recent accumulating evidence indicates the biological actions of Autotaxin-Lysophosphatidic acid (ATX-LPA) signaling axis in malignant tumors. However, the role of Autotaxin-Lysophosphatidic acid signaling axis in breast cancer has not been reported. The present study aims to examine the alterations...
Autores principales: | Shao, Yingbo, Yu, Yang, He, Yaning, Chen, Qi, Liu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456097/ https://www.ncbi.nlm.nih.gov/pubmed/30921203 http://dx.doi.org/10.1097/MD.0000000000014973 |
Ejemplares similares
-
A New Enzyme Immunoassay for the Quantitative Determination of Classical Autotaxins (ATXα, ATXβ, and ATXγ) and Novel Autotaxins (ATXδ and ATXε)
por: Tokuhara, Yasunori, et al.
Publicado: (2015) -
Evaluation of serum ATX and LPA as potential diagnostic biomarkers in patients with pancreatic cancer
por: Chen, Jiang, et al.
Publicado: (2021) -
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer
por: Shao, Yingbo, et al.
Publicado: (2015) -
lncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR-340-5p-dependent upregulation of SOX4
por: Yu, Yang, et al.
Publicado: (2020) -
Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism
por: He, Yaning, et al.
Publicado: (2019)